Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation

Completed · Phase 2 · Has a placebo group

Conditions studied: Insomnia

In brief

The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with alcohol use disorder (AUD) who experience insomnia associated with alcohol cessation, compared to placebo.

Key facts

Study ID
NCT04035200
Run by
Imbrium Therapeutics
People needed
114
Starts
2019-09-23
Expected to finish
2020-11-06
Last updated by the study team
2023-09-18

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.